Adenosine Receptors and the Heart: Role in Regulation of Coronary Blood Flow and Cardiac Electrophysiology
- 28 May 2009
- book chapter
- Published by Springer Nature
- No. 193,p. 161-188
- https://doi.org/10.1007/978-3-540-89615-9_6
Abstract
Adenosine is an autacoid that plays a critical role in regulating cardiac function, including heart rate, contractility, and coronary flow. In this chapter, current knowledge of the functions and mechanisms of action of coronary flow regulation and electrophysiology will be discussed. Currently, there are four known adenosine receptor (AR) subtypes, namely A1, A2A, A2B, and A3. All four subtypes are known to regulate coronary flow. In general, A2AAR is the predominant receptor subtype responsible for coronary blood flow regulation, which dilates coronary arteries in both an endothelial-dependent and -independent manner. The roles of other ARs and their mechanisms of action will also be discussed. The increasing popularity of gene-modified models with targeted deletion or overexpression of a single AR subtype has helped to elucidate the roles of each receptor subtype. Combining pharmacologic tools with targeted gene deletion of individual AR subtypes has proven invaluable for discriminating the vascular effects unique to the activation of each AR subtype. Adenosine exerts its cardiac electrophysiologic effects mainly through the activation of A1AR. This receptor mediates direct as well as indirect effects of adenosine (i.e., anti-β-adrenergic effects). In supraventricular tissues (atrial myocytes, sinuatrial node and atriovetricular node), adenosine exerts both direct and indirect effects, while it exerts only indirect effects in the ventricle. Adenosine exerts a negative chronotropic effect by suppressing the automaticity of cardiac pacemakers, and a negative dromotropic effect through inhibition of AV-nodal conduction. These effects of adenosine constitute the rationale for its use as a diagnostic and therapeutic agent. In recent years, efforts have been made to develop A1R-selective agonists as drug candidates that do not induce vasodilation, which is considered an undesirable effect in the clinical setting.Keywords
This publication has 188 references indexed in Scilit:
- Up-regulation of A2B adenosine receptor in A2A adenosine receptor knockout mouse coronary arteryJournal of Molecular and Cellular Cardiology, 2008
- The A2b adenosine receptor protects against vascular injuryProceedings of the National Academy of Sciences, 2008
- Aminophylline in bradyasystolic cardiac arrestEmergency Medicine Journal, 2007
- Enhanced mast cell activation in mice deficient in the A2b adenosine receptorThe Journal of Experimental Medicine, 2007
- Cl-IB-MECA [2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide] Reduces Ischemia/Reperfusion Injury in Mice by Activating the A Adenosine ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2006
- The protein kinase A inhibitor, H-89, directly inhibits KATP and Kir channels in rabbit coronary arterial smooth muscle cellsBiochemical and Biophysical Research Communications, 2006
- Substance P and bradykinin activate different types of KCa currents to hyperpolarize cultured porcine coronary artery endothelial cellsThe Journal of Physiology, 1999
- Modulation of protein kinase C by adenosine: Involvement of adenosine A1 receptor-pertussis toxin sensitive nucleotide binding protein systemMolecular and Cellular Biochemistry, 1995
- Digoxin-Induced ventricular arrhythmias in the guinea pig heart in vivo: Evidence for a role of endogenous catecholamines in the genesis of delayed afterdepolarizations and triggered activityHeart and Vessels, 1995
- Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.Circulation, 1983